Insulin-like Growth Factor-1 Receptor and ErbB Kinase Inhibitor Combinations Block Proliferation and Induce Apoptosis through Cyclin D1 Reduction and Bax Activation
Julie L. Wilsbacher(Harvard University), Jieyi Wang(AbbVie (United States))
Cited by 24
Related Papers
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
|BMC Cancer|2016|62
Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells
|BMC Cancer|2014|28
An active form of Vav1 induces migration of mammary epithelial cells by stimulating secretion of an epidermal growth factor receptor ligand
|Cell Communication and Signaling|2006|26